DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ advanced 2.77% to $123.70 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.41% to 5,916.93 and the Dow Jones Industrial Average rising 0.65% to 42,322.75.
The stock's rise snapped a two-day losing streak.
Biogen Inc. closed 48.03% below its 52-week high of $238.00, which the company achieved on July 12th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 2.22% to $149.61, Pfizer Inc. $(PFE)$ rose 2.63% to $22.60, and AbbVie Inc. $(ABBV)$ rose 2.39% to $181.68.
Trading volume (1.9 M) eclipsed its 50-day average volume of 1.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 15, 2025 17:10 ET (21:10 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。